Dr. Talton is a co-founder, President, and CEO at Nanotherapeutics. Prior to founding Nanotherapeutics, Dr. Talton was the President and CEO of D&E Management Systems, a leading service organization in Florida, from 1993 to 1994. Dr. Talton is a co-inventor of Nanotherapeutics' technologies and has several authored peer-reviewed publications and book chapters involved in drug delivery systems with a primary focus in drug analysis and controlled release formulations, pharmacokinetics, and pulmonary drug delivery. Dr. Talton received his B.S. and M.S. in Materials Science and Engineering and his Ph.D. in Pharmaceutical Sciences from the University of Florida. Dr. Talton is also a Director of BioFlorida, on the Advisory Council at Keck Graduate Institute, and has been a reviewer for the NIH for over ten years.